nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—CYP1A2—Carmustine—melanoma	0.154	0.229	CbGbCtD
Cinacalcet—CYP1A2—Vemurafenib—melanoma	0.122	0.181	CbGbCtD
Cinacalcet—CYP3A4—Temozolomide—melanoma	0.116	0.173	CbGbCtD
Cinacalcet—CYP2D6—Vemurafenib—melanoma	0.1	0.149	CbGbCtD
Cinacalcet—CYP1A2—Dacarbazine—melanoma	0.0932	0.139	CbGbCtD
Cinacalcet—CYP3A4—Vemurafenib—melanoma	0.0637	0.095	CbGbCtD
Cinacalcet—CYP3A4—Docetaxel—melanoma	0.0219	0.0326	CbGbCtD
Cinacalcet—Metastatic neoplasm—Temozolomide—melanoma	0.00885	0.0617	CcSEcCtD
Cinacalcet—Metastatic neoplasm—Docetaxel—melanoma	0.00589	0.041	CcSEcCtD
Cinacalcet—Multi-organ failure—Dactinomycin—melanoma	0.00576	0.0401	CcSEcCtD
Cinacalcet—Neoplasm malignant—Vemurafenib—melanoma	0.00389	0.0271	CcSEcCtD
Cinacalcet—Multi-organ failure—Docetaxel—melanoma	0.00346	0.0241	CcSEcCtD
Cinacalcet—Thrombosis—Carmustine—melanoma	0.00248	0.0173	CcSEcCtD
Cinacalcet—Pain in extremity—Vemurafenib—melanoma	0.00241	0.0168	CcSEcCtD
Cinacalcet—Hypocalcaemia—Dactinomycin—melanoma	0.00205	0.0143	CcSEcCtD
Cinacalcet—Oedema peripheral—Vemurafenib—melanoma	0.00164	0.0114	CcSEcCtD
Cinacalcet—Malnutrition—Vemurafenib—melanoma	0.00145	0.0101	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Carmustine—melanoma	0.00127	0.00888	CcSEcCtD
Cinacalcet—Cough—Vemurafenib—melanoma	0.00127	0.00883	CcSEcCtD
Cinacalcet—Bone disorder—Docetaxel—melanoma	0.00125	0.00871	CcSEcCtD
Cinacalcet—Arthralgia—Vemurafenib—melanoma	0.00124	0.00861	CcSEcCtD
Cinacalcet—Myalgia—Vemurafenib—melanoma	0.00124	0.00861	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00123	0.00855	CcSEcCtD
Cinacalcet—Infection—Vemurafenib—melanoma	0.00118	0.0082	CcSEcCtD
Cinacalcet—Nervous system disorder—Vemurafenib—melanoma	0.00116	0.0081	CcSEcCtD
Cinacalcet—Skin disorder—Vemurafenib—melanoma	0.00115	0.00802	CcSEcCtD
Cinacalcet—Dehydration—Temozolomide—melanoma	0.00115	0.00798	CcSEcCtD
Cinacalcet—Hypotension—Vemurafenib—melanoma	0.00111	0.00771	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00108	0.00752	CcSEcCtD
Cinacalcet—Decreased appetite—Vemurafenib—melanoma	0.00103	0.00718	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Vemurafenib—melanoma	0.00102	0.00713	CcSEcCtD
Cinacalcet—Fatigue—Vemurafenib—melanoma	0.00102	0.00712	CcSEcCtD
Cinacalcet—Constipation—Vemurafenib—melanoma	0.00101	0.00706	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Temozolomide—melanoma	0.00099	0.00689	CcSEcCtD
Cinacalcet—Depression—Carmustine—melanoma	0.00098	0.00683	CcSEcCtD
Cinacalcet—Depression—Temozolomide—melanoma	0.000947	0.0066	CcSEcCtD
Cinacalcet—Body temperature increased—Vemurafenib—melanoma	0.000937	0.00653	CcSEcCtD
Cinacalcet—Hypersensitivity—Vemurafenib—melanoma	0.000873	0.00608	CcSEcCtD
Cinacalcet—Oedema peripheral—Carmustine—melanoma	0.000869	0.00605	CcSEcCtD
Cinacalcet—Asthenia—Vemurafenib—melanoma	0.00085	0.00592	CcSEcCtD
Cinacalcet—Oedema peripheral—Temozolomide—melanoma	0.00084	0.00585	CcSEcCtD
Cinacalcet—Cardiac failure—Docetaxel—melanoma	0.000839	0.00585	CcSEcCtD
Cinacalcet—Pruritus—Vemurafenib—melanoma	0.000838	0.00584	CcSEcCtD
Cinacalcet—Pain in extremity—Docetaxel—melanoma	0.000819	0.00571	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000819	0.00571	CcSEcCtD
Cinacalcet—Anaemia—Bleomycin—melanoma	0.000813	0.00566	CcSEcCtD
Cinacalcet—Diarrhoea—Vemurafenib—melanoma	0.000811	0.00565	CcSEcCtD
Cinacalcet—Arrhythmia—Carmustine—melanoma	0.000788	0.00549	CcSEcCtD
Cinacalcet—Dizziness—Vemurafenib—melanoma	0.000783	0.00546	CcSEcCtD
Cinacalcet—Immune system disorder—Temozolomide—melanoma	0.00077	0.00536	CcSEcCtD
Cinacalcet—Malnutrition—Carmustine—melanoma	0.000768	0.00535	CcSEcCtD
Cinacalcet—Cough—Bleomycin—melanoma	0.000767	0.00535	CcSEcCtD
Cinacalcet—Dehydration—Docetaxel—melanoma	0.000762	0.00531	CcSEcCtD
Cinacalcet—Anaemia—Dactinomycin—melanoma	0.000758	0.00528	CcSEcCtD
Cinacalcet—Vomiting—Vemurafenib—melanoma	0.000753	0.00525	CcSEcCtD
Cinacalcet—Chest pain—Bleomycin—melanoma	0.000749	0.00522	CcSEcCtD
Cinacalcet—Myalgia—Bleomycin—melanoma	0.000749	0.00522	CcSEcCtD
Cinacalcet—Rash—Vemurafenib—melanoma	0.000747	0.0052	CcSEcCtD
Cinacalcet—Dermatitis—Vemurafenib—melanoma	0.000746	0.0052	CcSEcCtD
Cinacalcet—Headache—Vemurafenib—melanoma	0.000742	0.00517	CcSEcCtD
Cinacalcet—Malnutrition—Temozolomide—melanoma	0.000742	0.00517	CcSEcCtD
Cinacalcet—Cramp muscle—Docetaxel—melanoma	0.000738	0.00514	CcSEcCtD
Cinacalcet—Infection—Bleomycin—melanoma	0.000713	0.00497	CcSEcCtD
Cinacalcet—Anaemia—Carmustine—melanoma	0.00071	0.00494	CcSEcCtD
Cinacalcet—Nausea—Vemurafenib—melanoma	0.000704	0.0049	CcSEcCtD
Cinacalcet—Myalgia—Dactinomycin—melanoma	0.000698	0.00487	CcSEcCtD
Cinacalcet—Anaemia—Temozolomide—melanoma	0.000686	0.00478	CcSEcCtD
Cinacalcet—Anorexia—Bleomycin—melanoma	0.000684	0.00477	CcSEcCtD
Cinacalcet—Angioedema—Temozolomide—melanoma	0.000678	0.00472	CcSEcCtD
Cinacalcet—Hypotension—Bleomycin—melanoma	0.000671	0.00467	CcSEcCtD
Cinacalcet—Convulsion—Carmustine—melanoma	0.000665	0.00463	CcSEcCtD
Cinacalcet—Infection—Dactinomycin—melanoma	0.000665	0.00463	CcSEcCtD
Cinacalcet—Hypertension—Carmustine—melanoma	0.000663	0.00462	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Bleomycin—melanoma	0.000654	0.00456	CcSEcCtD
Cinacalcet—Myalgia—Carmustine—melanoma	0.000654	0.00455	CcSEcCtD
Cinacalcet—Chest pain—Carmustine—melanoma	0.000654	0.00455	CcSEcCtD
Cinacalcet—Cough—Temozolomide—melanoma	0.000647	0.00451	CcSEcCtD
Cinacalcet—Paraesthesia—Bleomycin—melanoma	0.000645	0.00449	CcSEcCtD
Cinacalcet—Convulsion—Temozolomide—melanoma	0.000643	0.00448	CcSEcCtD
Cinacalcet—Hypertension—Temozolomide—melanoma	0.000641	0.00446	CcSEcCtD
Cinacalcet—Dyspnoea—Bleomycin—melanoma	0.00064	0.00446	CcSEcCtD
Cinacalcet—Anorexia—Dactinomycin—melanoma	0.000638	0.00445	CcSEcCtD
Cinacalcet—Floctafenine—PTGS2—melanoma	0.000632	0.49	CrCbGaD
Cinacalcet—Myalgia—Temozolomide—melanoma	0.000632	0.0044	CcSEcCtD
Cinacalcet—Arthralgia—Temozolomide—melanoma	0.000632	0.0044	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000627	0.00437	CcSEcCtD
Cinacalcet—Decreased appetite—Bleomycin—melanoma	0.000624	0.00435	CcSEcCtD
Cinacalcet—Infection—Carmustine—melanoma	0.000622	0.00434	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00061	0.00425	CcSEcCtD
Cinacalcet—Infection—Temozolomide—melanoma	0.000602	0.00419	CcSEcCtD
Cinacalcet—Anorexia—Carmustine—melanoma	0.000597	0.00416	CcSEcCtD
Cinacalcet—Nervous system disorder—Temozolomide—melanoma	0.000594	0.00414	CcSEcCtD
Cinacalcet—Skin disorder—Temozolomide—melanoma	0.000588	0.0041	CcSEcCtD
Cinacalcet—Hypotension—Carmustine—melanoma	0.000585	0.00408	CcSEcCtD
Cinacalcet—Decreased appetite—Dactinomycin—melanoma	0.000582	0.00405	CcSEcCtD
Cinacalcet—Fatigue—Dactinomycin—melanoma	0.000577	0.00402	CcSEcCtD
Cinacalcet—Anorexia—Temozolomide—melanoma	0.000577	0.00402	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Carmustine—melanoma	0.000571	0.00398	CcSEcCtD
Cinacalcet—Urticaria—Bleomycin—melanoma	0.00057	0.00397	CcSEcCtD
Cinacalcet—Body temperature increased—Bleomycin—melanoma	0.000567	0.00395	CcSEcCtD
Cinacalcet—Paraesthesia—Carmustine—melanoma	0.000563	0.00392	CcSEcCtD
Cinacalcet—Dyspnoea—Carmustine—melanoma	0.000559	0.00389	CcSEcCtD
Cinacalcet—Oedema peripheral—Docetaxel—melanoma	0.000558	0.00389	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Temozolomide—melanoma	0.000552	0.00384	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Dactinomycin—melanoma	0.000547	0.00381	CcSEcCtD
Cinacalcet—Decreased appetite—Carmustine—melanoma	0.000545	0.00379	CcSEcCtD
Cinacalcet—Paraesthesia—Temozolomide—melanoma	0.000544	0.00379	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Carmustine—melanoma	0.000541	0.00377	CcSEcCtD
Cinacalcet—Dyspnoea—Temozolomide—melanoma	0.00054	0.00376	CcSEcCtD
Cinacalcet—Constipation—Carmustine—melanoma	0.000536	0.00373	CcSEcCtD
Cinacalcet—Dyspepsia—Temozolomide—melanoma	0.000533	0.00371	CcSEcCtD
Cinacalcet—Abdominal pain—Dactinomycin—melanoma	0.000529	0.00369	CcSEcCtD
Cinacalcet—Body temperature increased—Dactinomycin—melanoma	0.000529	0.00369	CcSEcCtD
Cinacalcet—Hypersensitivity—Bleomycin—melanoma	0.000529	0.00368	CcSEcCtD
Cinacalcet—Decreased appetite—Temozolomide—melanoma	0.000526	0.00367	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Temozolomide—melanoma	0.000523	0.00364	CcSEcCtD
Cinacalcet—Fatigue—Temozolomide—melanoma	0.000522	0.00364	CcSEcCtD
Cinacalcet—Constipation—Temozolomide—melanoma	0.000518	0.00361	CcSEcCtD
Cinacalcet—Asthenia—Bleomycin—melanoma	0.000515	0.00359	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Carmustine—melanoma	0.000512	0.00357	CcSEcCtD
Cinacalcet—Immune system disorder—Docetaxel—melanoma	0.000512	0.00357	CcSEcCtD
Cinacalcet—Pruritus—Bleomycin—melanoma	0.000508	0.00354	CcSEcCtD
Cinacalcet—Arrhythmia—Docetaxel—melanoma	0.000506	0.00353	CcSEcCtD
Cinacalcet—Body temperature increased—Carmustine—melanoma	0.000495	0.00345	CcSEcCtD
Cinacalcet—Abdominal pain—Carmustine—melanoma	0.000495	0.00345	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Temozolomide—melanoma	0.000495	0.00345	CcSEcCtD
Cinacalcet—Malnutrition—Docetaxel—melanoma	0.000493	0.00344	CcSEcCtD
Cinacalcet—Hypersensitivity—Dactinomycin—melanoma	0.000493	0.00344	CcSEcCtD
Cinacalcet—Urticaria—Temozolomide—melanoma	0.000481	0.00335	CcSEcCtD
Cinacalcet—Asthenia—Dactinomycin—melanoma	0.00048	0.00335	CcSEcCtD
Cinacalcet—Abdominal pain—Temozolomide—melanoma	0.000479	0.00333	CcSEcCtD
Cinacalcet—Body temperature increased—Temozolomide—melanoma	0.000479	0.00333	CcSEcCtD
Cinacalcet—Muscle spasms—Docetaxel—melanoma	0.000474	0.0033	CcSEcCtD
Cinacalcet—Hypersensitivity—Carmustine—melanoma	0.000462	0.00322	CcSEcCtD
Cinacalcet—Diarrhoea—Dactinomycin—melanoma	0.000458	0.00319	CcSEcCtD
Cinacalcet—Vomiting—Bleomycin—melanoma	0.000456	0.00318	CcSEcCtD
Cinacalcet—Anaemia—Docetaxel—melanoma	0.000456	0.00318	CcSEcCtD
Cinacalcet—Rash—Bleomycin—melanoma	0.000453	0.00315	CcSEcCtD
Cinacalcet—Dermatitis—Bleomycin—melanoma	0.000452	0.00315	CcSEcCtD
Cinacalcet—Asthenia—Carmustine—melanoma	0.00045	0.00313	CcSEcCtD
Cinacalcet—Hypersensitivity—Temozolomide—melanoma	0.000446	0.00311	CcSEcCtD
Cinacalcet—Asthenia—Temozolomide—melanoma	0.000434	0.00303	CcSEcCtD
Cinacalcet—Cough—Docetaxel—melanoma	0.000431	0.003	CcSEcCtD
Cinacalcet—Diarrhoea—Carmustine—melanoma	0.000429	0.00299	CcSEcCtD
Cinacalcet—Pruritus—Temozolomide—melanoma	0.000428	0.00298	CcSEcCtD
Cinacalcet—Convulsion—Docetaxel—melanoma	0.000427	0.00298	CcSEcCtD
Cinacalcet—Nausea—Bleomycin—melanoma	0.000426	0.00297	CcSEcCtD
Cinacalcet—Hypertension—Docetaxel—melanoma	0.000426	0.00297	CcSEcCtD
Cinacalcet—Vomiting—Dactinomycin—melanoma	0.000426	0.00297	CcSEcCtD
Cinacalcet—Rash—Dactinomycin—melanoma	0.000422	0.00294	CcSEcCtD
Cinacalcet—Arthralgia—Docetaxel—melanoma	0.00042	0.00293	CcSEcCtD
Cinacalcet—Chest pain—Docetaxel—melanoma	0.00042	0.00293	CcSEcCtD
Cinacalcet—Myalgia—Docetaxel—melanoma	0.00042	0.00293	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000417	0.00291	CcSEcCtD
Cinacalcet—Dizziness—Carmustine—melanoma	0.000414	0.00289	CcSEcCtD
Cinacalcet—Diarrhoea—Temozolomide—melanoma	0.000414	0.00289	CcSEcCtD
Cinacalcet—Dizziness—Temozolomide—melanoma	0.0004	0.00279	CcSEcCtD
Cinacalcet—Infection—Docetaxel—melanoma	0.0004	0.00279	CcSEcCtD
Cinacalcet—Vomiting—Carmustine—melanoma	0.000398	0.00278	CcSEcCtD
Cinacalcet—Nausea—Dactinomycin—melanoma	0.000398	0.00277	CcSEcCtD
Cinacalcet—Rash—Carmustine—melanoma	0.000395	0.00275	CcSEcCtD
Cinacalcet—Nervous system disorder—Docetaxel—melanoma	0.000395	0.00275	CcSEcCtD
Cinacalcet—Dermatitis—Carmustine—melanoma	0.000395	0.00275	CcSEcCtD
Cinacalcet—Headache—Carmustine—melanoma	0.000393	0.00273	CcSEcCtD
Cinacalcet—Skin disorder—Docetaxel—melanoma	0.000391	0.00273	CcSEcCtD
Cinacalcet—Vomiting—Temozolomide—melanoma	0.000385	0.00268	CcSEcCtD
Cinacalcet—Anorexia—Docetaxel—melanoma	0.000384	0.00267	CcSEcCtD
Cinacalcet—Rash—Temozolomide—melanoma	0.000382	0.00266	CcSEcCtD
Cinacalcet—Dermatitis—Temozolomide—melanoma	0.000381	0.00266	CcSEcCtD
Cinacalcet—Headache—Temozolomide—melanoma	0.000379	0.00264	CcSEcCtD
Cinacalcet—Hypotension—Docetaxel—melanoma	0.000376	0.00262	CcSEcCtD
Cinacalcet—Nausea—Carmustine—melanoma	0.000372	0.00259	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Docetaxel—melanoma	0.000367	0.00256	CcSEcCtD
Cinacalcet—Paraesthesia—Docetaxel—melanoma	0.000362	0.00252	CcSEcCtD
Cinacalcet—Nausea—Temozolomide—melanoma	0.00036	0.00251	CcSEcCtD
Cinacalcet—Dyspnoea—Docetaxel—melanoma	0.000359	0.0025	CcSEcCtD
Cinacalcet—Dyspepsia—Docetaxel—melanoma	0.000354	0.00247	CcSEcCtD
Cinacalcet—Decreased appetite—Docetaxel—melanoma	0.00035	0.00244	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Docetaxel—melanoma	0.000348	0.00242	CcSEcCtD
Cinacalcet—Fatigue—Docetaxel—melanoma	0.000347	0.00242	CcSEcCtD
Cinacalcet—Constipation—Docetaxel—melanoma	0.000344	0.0024	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Docetaxel—melanoma	0.000329	0.00229	CcSEcCtD
Cinacalcet—Abdominal pain—Docetaxel—melanoma	0.000318	0.00222	CcSEcCtD
Cinacalcet—Body temperature increased—Docetaxel—melanoma	0.000318	0.00222	CcSEcCtD
Cinacalcet—Hypersensitivity—Docetaxel—melanoma	0.000297	0.00207	CcSEcCtD
Cinacalcet—Asthenia—Docetaxel—melanoma	0.000289	0.00201	CcSEcCtD
Cinacalcet—Pruritus—Docetaxel—melanoma	0.000285	0.00198	CcSEcCtD
Cinacalcet—Diarrhoea—Docetaxel—melanoma	0.000276	0.00192	CcSEcCtD
Cinacalcet—Dizziness—Docetaxel—melanoma	0.000266	0.00186	CcSEcCtD
Cinacalcet—Vomiting—Docetaxel—melanoma	0.000256	0.00178	CcSEcCtD
Cinacalcet—Rash—Docetaxel—melanoma	0.000254	0.00177	CcSEcCtD
Cinacalcet—Dermatitis—Docetaxel—melanoma	0.000254	0.00177	CcSEcCtD
Cinacalcet—Headache—Docetaxel—melanoma	0.000252	0.00176	CcSEcCtD
Cinacalcet—Nausea—Docetaxel—melanoma	0.000239	0.00167	CcSEcCtD
Cinacalcet—Fluoxetine—ALB—melanoma	0.000199	0.154	CrCbGaD
Cinacalcet—Fluoxetine—ABCB1—melanoma	0.00019	0.147	CrCbGaD
Cinacalcet—CASR—Signaling Pathways—GNAQ—melanoma	0.000155	0.00084	CbGpPWpGaD
Cinacalcet—Triflupromazine—ABCB1—melanoma	0.000155	0.12	CrCbGaD
Cinacalcet—CYP2D6—Melatonin metabolism and effects—NFKB1—melanoma	0.000152	0.000825	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—melanoma	0.000152	0.000824	CbGpPWpGaD
Cinacalcet—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000149	0.000809	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—PIK3CG—melanoma	0.000149	0.000809	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SYK—melanoma	0.000146	0.00079	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—PIK3CD—melanoma	0.000145	0.000783	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NGFR—melanoma	0.000143	0.000775	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ITGAV—melanoma	0.000143	0.000775	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—AKT3—melanoma	0.000143	0.000775	CbGpPWpGaD
Cinacalcet—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.000142	0.00077	CbGpPWpGaD
Cinacalcet—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.00014	0.00076	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	0.000139	0.000752	CbGpPWpGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.000137	0.000742	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SOCS1—melanoma	0.000133	0.000718	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—MAP2K1—melanoma	0.000132	0.000716	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—S100B—melanoma	0.000132	0.000716	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—PIK3CD—melanoma	0.000131	0.000711	CbGpPWpGaD
Cinacalcet—CYP1A2—Melatonin metabolism and effects—NFKB1—melanoma	0.000129	0.000699	CbGpPWpGaD
Cinacalcet—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000128	0.000695	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ERBB4—melanoma	0.000126	0.000685	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—PIK3CB—melanoma	0.000126	0.000683	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CDKN2B—melanoma	0.000125	0.000679	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—RB1—melanoma	0.000125	0.000677	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CD86—melanoma	0.000121	0.000656	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—CXCL8—melanoma	0.000121	0.000656	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—EDN1—melanoma	0.00012	0.000651	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—melanoma	0.00012	0.000649	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.000119	0.000643	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—FGF1—melanoma	0.000118	0.000637	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CSF2—melanoma	0.000118	0.000637	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—IL2—melanoma	0.000116	0.000627	CbGpPWpGaD
Cinacalcet—Propranolol—ABCB1—melanoma	0.000116	0.0897	CrCbGaD
Cinacalcet—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000115	0.000625	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—E2F1—melanoma	0.000115	0.000623	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—PIK3CB—melanoma	0.000114	0.00062	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PDGFRA—melanoma	0.000114	0.000616	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ITGB3—melanoma	0.000113	0.00061	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PRKCA—melanoma	0.000113	0.00061	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—CYP17A1—melanoma	0.000111	0.000603	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—SPP1—melanoma	0.000111	0.000598	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MAP2K2—melanoma	0.00011	0.000597	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—CXCL8—melanoma	0.00011	0.000596	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—CYP17A1—melanoma	0.00011	0.000595	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—melanoma	0.000107	0.00058	CbGpPWpGaD
Cinacalcet—CYP1A2—Tryptophan metabolism—MDM2—melanoma	0.000107	0.000577	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL2—melanoma	0.000105	0.000569	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TERT—melanoma	0.000105	0.000567	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—RAC1—melanoma	0.000104	0.000566	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—melanoma	0.000103	0.000556	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—HIF1A—melanoma	0.0001	0.000543	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—melanoma	9.73e-05	0.000527	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—melanoma	9.73e-05	0.000527	CbGpPWpGaD
Cinacalcet—CYP1A2—Arachidonic acid metabolism—PTGS2—melanoma	9.61e-05	0.000521	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—KDR—melanoma	9.58e-05	0.000519	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—melanoma	9.52e-05	0.000516	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—CYP17A1—melanoma	9.43e-05	0.000511	CbGpPWpGaD
Cinacalcet—CYP2D6—Biological oxidations—CYP1B1—melanoma	9.37e-05	0.000507	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—CYP17A1—melanoma	9.3e-05	0.000504	CbGpPWpGaD
Cinacalcet—CYP2D6—Metapathway biotransformation—CYP1B1—melanoma	9.24e-05	0.0005	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—FN1—melanoma	9.22e-05	0.000499	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NOTCH1—melanoma	9.03e-05	0.000489	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—melanoma	8.98e-05	0.000486	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—melanoma	8.92e-05	0.000483	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CD80—melanoma	8.84e-05	0.000479	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PIK3CG—melanoma	8.83e-05	0.000478	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—KIT—melanoma	8.83e-05	0.000478	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—APC—melanoma	8.83e-05	0.000478	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—NRAS—melanoma	8.83e-05	0.000478	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—EGF—melanoma	8.72e-05	0.000472	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—MAPK3—melanoma	8.45e-05	0.000458	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—BRAF—melanoma	8.3e-05	0.000449	CbGpPWpGaD
Cinacalcet—CYP3A4—Tryptophan metabolism—MDM2—melanoma	8.23e-05	0.000445	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—melanoma	8.09e-05	0.000438	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IGF1—melanoma	8.08e-05	0.000438	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—MAPK1—melanoma	8.04e-05	0.000436	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—EGFR—melanoma	8.04e-05	0.000435	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—melanoma	7.99e-05	0.000433	CbGpPWpGaD
Cinacalcet—CYP1A2—Biological oxidations—CYP1B1—melanoma	7.94e-05	0.00043	CbGpPWpGaD
Cinacalcet—CYP1A2—Metapathway biotransformation—CYP1B1—melanoma	7.83e-05	0.000424	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MAP2K1—melanoma	7.81e-05	0.000423	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PIK3CD—melanoma	7.76e-05	0.00042	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—PIK3CA—melanoma	7.69e-05	0.000416	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—KRAS—melanoma	7.6e-05	0.000411	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—MYC—melanoma	7.45e-05	0.000403	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—FGF2—melanoma	7.43e-05	0.000402	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—melanoma	7.29e-05	0.000395	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—melanoma	7.28e-05	0.000394	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—melanoma	7.28e-05	0.000394	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—CYP17A1—melanoma	7.28e-05	0.000394	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	7.2e-05	0.00039	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	7.18e-05	0.000389	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—PIK3CA—melanoma	6.98e-05	0.000378	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MDM2—melanoma	6.95e-05	0.000376	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—melanoma	6.94e-05	0.000376	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—TNF—melanoma	6.94e-05	0.000376	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—melanoma	6.88e-05	0.000373	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—ERBB2—melanoma	6.85e-05	0.000371	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PIK3CB—melanoma	6.76e-05	0.000366	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CXCL8—melanoma	6.5e-05	0.000352	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—HRAS—melanoma	6.46e-05	0.00035	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CDKN1B—melanoma	6.35e-05	0.000344	CbGpPWpGaD
Cinacalcet—CASR—GPCR downstream signaling—AKT1—melanoma	6.28e-05	0.00034	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ACER3—melanoma	6.25e-05	0.000338	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CASP3—melanoma	6.22e-05	0.000337	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL2—melanoma	6.21e-05	0.000336	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—IL6—melanoma	6.18e-05	0.000335	CbGpPWpGaD
Cinacalcet—CYP3A4—Biological oxidations—CYP1B1—melanoma	6.13e-05	0.000332	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CCND1—melanoma	6.05e-05	0.000328	CbGpPWpGaD
Cinacalcet—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	6.04e-05	0.000327	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CUBN—melanoma	6.01e-05	0.000325	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CTNNB1—melanoma	6e-05	0.000325	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MMP9—melanoma	5.88e-05	0.000318	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—CDKN1A—melanoma	5.86e-05	0.000317	CbGpPWpGaD
Cinacalcet—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—melanoma	5.85e-05	0.000317	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PTEN—melanoma	5.84e-05	0.000316	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NFKB1—melanoma	5.82e-05	0.000315	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—UGT2B10—melanoma	5.71e-05	0.000309	CbGpPWpGaD
Cinacalcet—CASR—Signaling by GPCR—AKT1—melanoma	5.7e-05	0.000309	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—GPAM—melanoma	5.62e-05	0.000304	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—HS3ST5—melanoma	5.31e-05	0.000288	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ACER3—melanoma	5.29e-05	0.000287	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—VEGFA—melanoma	5.28e-05	0.000286	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—STAT3—melanoma	5.23e-05	0.000283	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—NRAS—melanoma	5.21e-05	0.000282	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MAPK3—melanoma	4.99e-05	0.00027	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MYC—melanoma	4.86e-05	0.000263	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—UGT2B10—melanoma	4.84e-05	0.000262	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	4.78e-05	0.000259	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—MAPK1—melanoma	4.75e-05	0.000257	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—EGFR—melanoma	4.75e-05	0.000257	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—HS3ST5—melanoma	4.5e-05	0.000244	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—KRAS—melanoma	4.49e-05	0.000243	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—PIK3CA—melanoma	4.12e-05	0.000223	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ACER3—melanoma	4.08e-05	0.000221	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PLCB4—melanoma	4.03e-05	0.000218	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—TP53—melanoma	3.99e-05	0.000216	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—HRAS—melanoma	3.81e-05	0.000207	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SLC6A11—melanoma	3.78e-05	0.000205	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIP4K2A—melanoma	3.78e-05	0.000205	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—UGT2B10—melanoma	3.74e-05	0.000202	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—MTAP—melanoma	3.68e-05	0.000199	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—IL6—melanoma	3.65e-05	0.000198	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	3.62e-05	0.000196	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—HS3ST5—melanoma	3.47e-05	0.000188	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PLCB4—melanoma	3.41e-05	0.000185	CbGpPWpGaD
Cinacalcet—CASR—Signaling Pathways—AKT1—melanoma	3.37e-05	0.000182	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	3.35e-05	0.000181	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—LUM—melanoma	3.28e-05	0.000178	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PHGDH—melanoma	3.28e-05	0.000178	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—HPSE—melanoma	3.22e-05	0.000174	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SLC6A11—melanoma	3.21e-05	0.000174	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIP4K2A—melanoma	3.21e-05	0.000174	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CUBN—melanoma	3.16e-05	0.000171	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—MTAP—melanoma	3.12e-05	0.000169	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—BSG—melanoma	3.05e-05	0.000165	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SDHD—melanoma	3.05e-05	0.000165	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CSPG4—melanoma	3.05e-05	0.000165	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.05e-05	0.000165	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GPAM—melanoma	2.95e-05	0.00016	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—LUM—melanoma	2.78e-05	0.000151	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PHGDH—melanoma	2.78e-05	0.000151	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—HPSE—melanoma	2.73e-05	0.000148	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CUBN—melanoma	2.68e-05	0.000145	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PLCB4—melanoma	2.63e-05	0.000143	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SDHD—melanoma	2.58e-05	0.00014	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CSPG4—melanoma	2.58e-05	0.00014	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—BSG—melanoma	2.58e-05	0.00014	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PLA2G6—melanoma	2.51e-05	0.000136	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GPAM—melanoma	2.5e-05	0.000136	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SLC6A11—melanoma	2.47e-05	0.000134	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIP4K2A—melanoma	2.47e-05	0.000134	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—MTAP—melanoma	2.41e-05	0.00013	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—VCAN—melanoma	2.26e-05	0.000122	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—LUM—melanoma	2.15e-05	0.000116	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PHGDH—melanoma	2.15e-05	0.000116	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PLA2G6—melanoma	2.13e-05	0.000115	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—HPSE—melanoma	2.1e-05	0.000114	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CUBN—melanoma	2.07e-05	0.000112	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SDHD—melanoma	1.99e-05	0.000108	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CSPG4—melanoma	1.99e-05	0.000108	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—BSG—melanoma	1.99e-05	0.000108	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GPAM—melanoma	1.93e-05	0.000105	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—VCAN—melanoma	1.91e-05	0.000104	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP17A1—melanoma	1.9e-05	0.000103	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.81e-05	9.8e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GNA11—melanoma	1.8e-05	9.74e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—FASN—melanoma	1.76e-05	9.53e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.75e-05	9.46e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SLC5A5—melanoma	1.73e-05	9.37e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GNAQ—melanoma	1.67e-05	9.05e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CD44—melanoma	1.67e-05	9.05e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PLA2G6—melanoma	1.64e-05	8.89e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP17A1—melanoma	1.61e-05	8.73e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP1B1—melanoma	1.6e-05	8.68e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.59e-05	8.61e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.57e-05	8.5e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GNA11—melanoma	1.52e-05	8.25e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—FASN—melanoma	1.49e-05	8.07e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—VCAN—melanoma	1.48e-05	7.99e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SLC5A5—melanoma	1.47e-05	7.94e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GNAQ—melanoma	1.42e-05	7.67e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CD44—melanoma	1.42e-05	7.67e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.39e-05	7.51e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.37e-05	7.44e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP1B1—melanoma	1.36e-05	7.35e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ABCB1—melanoma	1.32e-05	7.15e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP17A1—melanoma	1.24e-05	6.74e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PRKCA—melanoma	1.21e-05	6.58e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ERCC2—melanoma	1.2e-05	6.52e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.2e-05	6.49e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GNA11—melanoma	1.18e-05	6.37e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—FASN—melanoma	1.15e-05	6.23e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SLC5A5—melanoma	1.13e-05	6.13e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ABCB1—melanoma	1.12e-05	6.05e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GNAQ—melanoma	1.09e-05	5.92e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CD44—melanoma	1.09e-05	5.92e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP1B1—melanoma	1.05e-05	5.67e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PRKCA—melanoma	1.03e-05	5.57e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ERCC2—melanoma	1.02e-05	5.53e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CG—melanoma	9.51e-06	5.15e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PPARG—melanoma	9.18e-06	4.97e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ABCB1—melanoma	8.63e-06	4.67e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.45e-06	4.58e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CD—melanoma	8.36e-06	4.53e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ALB—melanoma	8.25e-06	4.47e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CG—melanoma	8.06e-06	4.36e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PRKCA—melanoma	7.94e-06	4.3e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ERCC2—melanoma	7.87e-06	4.26e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PPARG—melanoma	7.78e-06	4.21e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CB—melanoma	7.29e-06	3.95e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PTGS2—melanoma	7.22e-06	3.91e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CD—melanoma	7.08e-06	3.84e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ALB—melanoma	6.99e-06	3.79e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PTEN—melanoma	6.3e-06	3.41e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CG—melanoma	6.22e-06	3.37e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CB—melanoma	6.17e-06	3.34e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PTGS2—melanoma	6.12e-06	3.31e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PPARG—melanoma	6e-06	3.25e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CD—melanoma	5.47e-06	2.96e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ALB—melanoma	5.4e-06	2.92e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PTEN—melanoma	5.34e-06	2.89e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CB—melanoma	4.77e-06	2.58e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PTGS2—melanoma	4.72e-06	2.56e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CA—melanoma	4.44e-06	2.41e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PTEN—melanoma	4.12e-06	2.23e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CA—melanoma	3.76e-06	2.04e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—AKT1—melanoma	3.63e-06	1.97e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—AKT1—melanoma	3.07e-06	1.67e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CA—melanoma	2.91e-06	1.57e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—AKT1—melanoma	2.37e-06	1.29e-05	CbGpPWpGaD
